Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cellular Dynamics International, Inc. - ICEL

BALA CYNWYD, Pa., March 31, 2015 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cellular Dynamics International, Inc. ("Cellular Dynamics" or "the Company") (Nasdaq: ICEL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to FUJIFILM Holdings Corporation. ("FUJIFILM").

Click here to learn more about the investigation http://brodsky-smith.com/912-icel-cellular-dynamics-international-inc.html, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, Cellular Dynamics shareholders will receive only $16.50 in cash for each share of Cellular Dynamics stock they own. The investigation concerns whether the Board of  Cellular Dynamics breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether FUJIFILM is underpaying for Cellular Dynamics. The transaction may undervalue Cellular Dynamics given the growth potential of the Company's technology platform. The technology platform enables the production of high-quality fully functioning human cells, including induced pluripotent stem cells on an industrial scale. In addition, the transaction will result in a loss for many long term holders of Cellular Dynamics stock which has traded at $21.49 per share.  

If you own shares of Cellular Dynamics stock and wish to discuss the legal ramifications of   the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA  19004, by visiting http://brodsky-smith.com/912-icel-cellular-dynamics-international-inc.html, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert--brodsky---smith-llc-announces--investigation-of-the-board-of-directors-of-cellular-dynamics-international-inc---icel-300059030.html

SOURCE Brodsky & Smith, LLC